Intellectual Property

The CAN-BD process and the PuffHaler™ is based on the methods and devices invented and developed by Sievers, Cape, Carpenter, and coworkers, which are licensed to AKTIV-DRY™


Sievers, R.E. and Karst, U. US Patent 5639441 (1997)

Sievers, R.E. and Karst, U. US Patent 6095134 (2000)

Sievers, R.E., Sellers, S.P. and Carpenter, J.F., WO 00/75281 A2 (2001); national phase entered in UK, Japan, Australia, Italy, Spain, Germany, France, Switzerland;

Sievers, R.E. and Karst, U. European patent 0677332 B1, Feb.27, 2002; registered in UK, Germany, France, Switzerland. (2002)

Sievers, R.E., Sellers, S.P. and Carpenter, J.F., US Patent 6,630,121 (2003)

Sievers, R.E., Australian Patent 782916, Sept. 8, 2005 (2005)
 
Sievers, R.E., Sellers, S.P. and Carpenter, J.F., Chinese Patent ZL 00811293.2 (2005)

The PuffHaler™ Dry Powder Inhaler and Myo-inositol Stabilizer Compositions. US Patent Application 0035143 A1, February 14, 2008R. E. Sievers, J. A. Best & S. P. Cape. (2008)

"Methods and Apparatus for Fine Particle Formulation" European patent 01202801.5, July 29, 2009; registered in Germany, France, Great Britain, and Switzerland/Liechtenstein (2009)

Other patent applications have been filed that are divisionals of the CAN-BD patent filed April 8, 1994, and the European application.